No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Wednesday, October 22, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

Is HCA Healthcare Stock Underperforming the Dow?

by TheAdviserMagazine
2 months ago
in Business
Reading Time: 3 mins read
A A
Is HCA Healthcare Stock Underperforming the Dow?
Share on FacebookShare on TwitterShare on LInkedIn


HCA Healthcare, Inc. (HCA), based in Nashville, Tennessee, is a leading operator of an extensive network of healthcare facilities throughout the United States and the United Kingdom. The company owns, manages, or operates nearly 190 hospitals and roughly 2,400 additional sites of care, including ambulatory surgery centers, freestanding emergency departments, urgent care clinics, diagnostic centers, and more. HCA Healthcare’s market capitalization stands at approximately $96.4 billion, reflecting its substantial scale in the healthcare services sector.

Companies with a market cap of $10 billion or more are typically classified as “large-cap stocks,” denoting established firms with robust financial firepower and notable market presence. HCA Healthcare stands comfortably within this tier. This status highlights HCA’s entrenched dominance in the healthcare services arena, characterized by a powerful brand, an extensive care network, and the capacity to deliver efficient and comprehensive medical services at scale.

HCA stock has reached a fresh 52-week high of $417.20 on Sept. 4. Shares of the healthcare services operator have gained 7.8% over the past three months, slightly outperforming the broader Dow Jones Industrial Average’s ($DOWI) 7.5% rise over the same time frame.

www.barchart.com

Longer term, HCA stock is up 37.1% on a year-to-date (YTD) basis, outpacing Dow Jones’ 7.2% gains. Meanwhile, the stock has delivered around 4.4% returns over the past 52 weeks, compared to DOWI’s 11.3% returns over the same time frame.

HCA spent months wrestling below its 50-day moving average as sellers dominated late 2024. But by spring 2025, buyers took charge, driving a golden crossover as the 50-day pierced above the 200-day around June. HCA’s story flipped after months of drifting, and since June, it has been cruising above the 200-day moving average, and consistently leapt past the 50-day mark since January, although with slight fluctuations.

Each pullback has been shallow, hinting at strong buyer conviction. The trend now favors the bulls, with momentum building and dips getting scooped fast. Technicals suggest this rally might still have fuel left.

Story Continues

www.barchart.com
www.barchart.com

HCA’s stock performance has been shaped by strong underlying fundamentals on one hand, but cautious outlooks and broader sector headwinds persist, including deflated patient volumes and regulatory upheavals.

Its top rival, Tenet Healthcare Corporation (THC), has far exceeded HCA, with 52.5% gains this year and 18.8% over the past year.

Wall Street analysts are moderately bullish on HCA’s prospects. The stock has a consensus “Moderate Buy” rating from the 26 analysts covering it, and the stock is trading above its mean price target of $401.73. But the Street-high target of $444 suggests an upside potential of 7.9%.

On the date of publication, Sristi Jayaswal did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com



Source link

Tags: DowHCAhealthcarestockunderperforming
ShareTweetShare
Previous Post

Trump’s GENIUS Act Won’t Knock UAE Off Crypto Throne

Next Post

The Synthetic Data Question in the Age of AI

Related Posts

edit post
Navan to aim for -8b valuation in Nasdaq IPO next week

Navan to aim for $7-8b valuation in Nasdaq IPO next week

by TheAdviserMagazine
October 22, 2025
0

Travel booking company Navan, formerly TripActions, will reportedly hold its IPO on Nasdaq next week at a company valuation...

edit post
Where Will It Be in 1 Year (Oct 22)

Where Will It Be in 1 Year (Oct 22)

by TheAdviserMagazine
October 22, 2025
0

2024 Getty Images / Getty Images Entertainment via Getty Images Shares of Rivian Automotive Inc. (NASDAQ: RIVN) are changing hands...

edit post
Willing to pay extra to build resilience in our supply chains: Piyush Goyal

Willing to pay extra to build resilience in our supply chains: Piyush Goyal

by TheAdviserMagazine
October 22, 2025
0

New Delhi: Commerce and Industry Minister Piyush Goyal on Wednesday said the government is addressing supply chain issues across all...

edit post
The U.S. government shutdown means investors are flying blind when it comes to high-quality data—and they like it that way

The U.S. government shutdown means investors are flying blind when it comes to high-quality data—and they like it that way

by TheAdviserMagazine
October 22, 2025
0

The U.S. government shutdown has halted federal economic data collection, leaving investors without official employment or inflation figures. Despite flying...

edit post
Germany to buy Rafael Spike missiles for €2b

Germany to buy Rafael Spike missiles for €2b

by TheAdviserMagazine
October 22, 2025
0

The German Army has decided to procure Spike missiles from Israel’s Rafael Advanced Defense Systems for €2 billion. The...

edit post
Genflow Biosciences announces second European patent application (GENFF:OTCMKTS)

Genflow Biosciences announces second European patent application (GENFF:OTCMKTS)

by TheAdviserMagazine
October 22, 2025
0

Genflow Biosciences (OTCQB:GENFF) on Wednesday announced that its second European patent application (Application No. 23821586.7, Publication No. EP4630038), titled "SIRT6...

Next Post
edit post
The Synthetic Data Question in the Age of AI

The Synthetic Data Question in the Age of AI

edit post
Utrecht’s energy software startup Zympler raises €1.5M

Utrecht’s energy software startup Zympler raises €1.5M

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

Baby Boomers Are Flocking to This Florida Town — but Not for the Weather

October 9, 2025
edit post
Navan to aim for -8b valuation in Nasdaq IPO next week

Navan to aim for $7-8b valuation in Nasdaq IPO next week

0
edit post
India, U.S. near trade deal with major tariff cuts, reduced Russian oil purchases

India, U.S. near trade deal with major tariff cuts, reduced Russian oil purchases

0
edit post
Robinhood lists BNB token

Robinhood lists BNB token

0
edit post
A wish list for Carney’s fall budget

A wish list for Carney’s fall budget

0
edit post
Usa Rare Earth (USAR): Dreht die Seltene-Erden-Aktie am kritischen 25-USD-Support?

Usa Rare Earth (USAR): Dreht die Seltene-Erden-Aktie am kritischen 25-USD-Support?

0
edit post
Workers Shed Light on the Biggest Shifts in the Workplace Now

Workers Shed Light on the Biggest Shifts in the Workplace Now

0
edit post
Navan to aim for -8b valuation in Nasdaq IPO next week

Navan to aim for $7-8b valuation in Nasdaq IPO next week

October 22, 2025
edit post
Robinhood lists BNB token

Robinhood lists BNB token

October 22, 2025
edit post
Usa Rare Earth (USAR): Dreht die Seltene-Erden-Aktie am kritischen 25-USD-Support?

Usa Rare Earth (USAR): Dreht die Seltene-Erden-Aktie am kritischen 25-USD-Support?

October 22, 2025
edit post
Beyond Meat shares surge as meme traders buy stock

Beyond Meat shares surge as meme traders buy stock

October 22, 2025
edit post
Where Will It Be in 1 Year (Oct 22)

Where Will It Be in 1 Year (Oct 22)

October 22, 2025
edit post
Willing to pay extra to build resilience in our supply chains: Piyush Goyal

Willing to pay extra to build resilience in our supply chains: Piyush Goyal

October 22, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Navan to aim for $7-8b valuation in Nasdaq IPO next week
  • Robinhood lists BNB token
  • Usa Rare Earth (USAR): Dreht die Seltene-Erden-Aktie am kritischen 25-USD-Support?
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.